nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0613	0.115	CbGpPWpGaD
Morphine—OPRL1—nervous system—Gilles de la Tourette syndrome	0.0577	0.124	CbGeAlD
Morphine—OPRL1—central nervous system—Gilles de la Tourette syndrome	0.0555	0.119	CbGeAlD
Morphine—OPRL1—brain—Gilles de la Tourette syndrome	0.0441	0.0945	CbGeAlD
Morphine—OPRD1—nervous system—Gilles de la Tourette syndrome	0.0297	0.0637	CbGeAlD
Morphine—OPRD1—central nervous system—Gilles de la Tourette syndrome	0.0286	0.0613	CbGeAlD
Morphine—OPRK1—nervous system—Gilles de la Tourette syndrome	0.0285	0.061	CbGeAlD
Morphine—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.0274	0.0588	CbGeAlD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0262	0.049	CbGpPWpGaD
Morphine—OPRM1—midbrain—Gilles de la Tourette syndrome	0.0247	0.0528	CbGeAlD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0229	0.043	CbGpPWpGaD
Morphine—OPRD1—brain—Gilles de la Tourette syndrome	0.0227	0.0487	CbGeAlD
Morphine—OPRK1—brain—Gilles de la Tourette syndrome	0.0218	0.0467	CbGeAlD
Morphine—OPRM1—nervous system—Gilles de la Tourette syndrome	0.0203	0.0434	CbGeAlD
Morphine—OPRM1—central nervous system—Gilles de la Tourette syndrome	0.0195	0.0418	CbGeAlD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0194	0.0363	CbGpPWpGaD
Morphine—OPRM1—brain—Gilles de la Tourette syndrome	0.0155	0.0332	CbGeAlD
Morphine—OPRL1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.0123	0.0231	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.012	0.0224	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0111	0.0209	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0109	0.0204	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0105	0.0198	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0101	0.0189	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00983	0.0184	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00979	0.0184	CbGpPWpGaD
Morphine—CYP2C8—brain—Gilles de la Tourette syndrome	0.00932	0.02	CbGeAlD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00912	0.0171	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00864	0.0162	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00839	0.0157	CbGpPWpGaD
Morphine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00826	0.0177	CbGeAlD
Morphine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00813	0.0174	CbGeAlD
Morphine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00795	0.017	CbGeAlD
Morphine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00782	0.0168	CbGeAlD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00781	0.0147	CbGpPWpGaD
Morphine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00711	0.0152	CbGeAlD
Morphine—UGT1A3—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00685	0.0128	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00658	0.0123	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00639	0.012	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00639	0.012	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—HDC—Gilles de la Tourette syndrome	0.00631	0.0118	CbGpPWpGaD
Morphine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00621	0.0133	CbGeAlD
Morphine—OPRL1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00595	0.0112	CbGpPWpGaD
Morphine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00584	0.0125	CbGeAlD
Morphine—UGT2B7—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00583	0.0109	CbGpPWpGaD
Morphine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00563	0.0121	CbGeAlD
Morphine—UGT2B4—Metabolism—HDC—Gilles de la Tourette syndrome	0.00551	0.0103	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—HDC—Gilles de la Tourette syndrome	0.00551	0.0103	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00547	0.0103	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00473	0.00888	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00464	0.0087	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0045	0.00844	CbGpPWpGaD
Morphine—ABCB1—brain—Gilles de la Tourette syndrome	0.00447	0.00957	CbGeAlD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0043	0.00807	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00419	0.00787	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00418	0.00784	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00417	0.00781	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00407	0.00763	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00395	0.0074	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00389	0.0073	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00377	0.00708	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00372	0.00697	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00369	0.00692	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00368	0.0069	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00366	0.00687	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00361	0.00677	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00358	0.00671	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00344	0.00645	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00341	0.0064	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00338	0.00633	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00336	0.00631	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00334	0.00626	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00334	0.00625	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00328	0.00615	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00323	0.00606	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00319	0.00598	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00314	0.00589	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00311	0.00583	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0031	0.00581	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00305	0.00573	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00295	0.00554	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00292	0.00548	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00288	0.00541	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00281	0.00527	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00273	0.00513	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00273	0.00511	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00273	0.00511	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00265	0.00498	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00254	0.00476	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—HDC—Gilles de la Tourette syndrome	0.00251	0.00471	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00247	0.00464	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00246	0.00462	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00239	0.00448	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00239	0.00448	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00235	0.00442	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00234	0.00438	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00223	0.00418	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00214	0.00401	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00208	0.0039	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00205	0.00384	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00204	0.00383	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00202	0.00379	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00202	0.00379	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00199	0.00374	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00194	0.00363	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00188	0.00353	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.0018	0.00338	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00178	0.00334	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00173	0.00325	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00159	0.00298	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00156	0.00293	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00154	0.00289	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00144	0.0027	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00144	0.00269	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.0014	0.00262	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00139	0.00261	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00135	0.00253	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00132	0.00247	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0013	0.00244	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00126	0.00237	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00126	0.00237	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00126	0.00236	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00123	0.0023	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00118	0.00221	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00114	0.00214	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00114	0.00214	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	0.00107	0.00202	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00107	0.002	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00106	0.00199	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00104	0.00194	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00189	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000966	0.00181	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000936	0.00176	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000913	0.00171	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000882	0.00165	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000881	0.00165	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000851	0.0016	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000826	0.00155	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0008	0.0015	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00077	0.00144	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000747	0.0014	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000745	0.0014	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000725	0.00136	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000696	0.0013	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000676	0.00127	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000675	0.00127	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000631	0.00118	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000612	0.00115	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000577	0.00108	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000571	0.00107	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000539	0.00101	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000473	0.000887	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.0004	0.000749	CbGpPWpGaD
